Vol 52, No 5 (2024)

Search Browse

Author Details

Issue	Section	Title	File
Vol 48, No 6 (2020)	CLINICAL GUIDELINES	Early administration of genetically engineered biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An experts’ opinion	(Rus)
Vol 49, No 7 (2021)	ARTICLES	Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study	(Rus)
Vol 49, No 7 (2021)	POINT OF VIEW	Immunological aspects of determination of an adequate biological treatment sequence for inflammatory bowel diseases: the expert board statement (St. Petersburg, May 22, 2021)	(Rus)